Senior insider sale
Chief Strategy & Dev. Officer at AGILON HEALTH, INC. — senior position signals high conviction
$2.21M
82.71K shares
What this filing means
DESAI VEERAL plans to sell 82.71K shares of AGILON HEALTH, INC. valued at approximately $2.21M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/23/2023ACC: 0001958244-23-000427
Officer· Chief Strategy & Dev. Officer
Since Apr 2021
82.71K
Shares to sell
$2.21M
Approx. market value
22.71K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Compensation- Stock Options
Compensation, Cashless exercise and same-day sale
4/27/2017
22.71KTotal acquired22.71K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/27/2017 | Compensation- Stock Options Compensation, Cashless exercise and same-day sale | 22.71K | — |
| Total | 22.71K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
60K
Market value
$1.57M
3/16/2023
Planned — Approximate Date
NYSEPlanned
Units to sell
22.71K
Market value
$645.0K
3/23/2023
Total
Units
82.71K
Value
$2.21M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/16/2023 | 60K | $1.57M | — | Completed |
| Planned — Approximate Date | ||||
3/23/2023 | 22.71K | $645.0K | NYSE | Planned |
| Total | 82.71K | $2.21M | ||